HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Vernon Bernardino has reiterated a Buy rating on Cassava Sciences (NASDAQ:SAVA), maintaining a $124 price target.
March 05, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cassava Sciences receives a reiterated Buy rating and a $124 price target from HC Wainwright & Co.
The reiteration of a Buy rating and a high price target by a reputable analyst firm like HC Wainwright & Co. typically instills confidence in investors, potentially leading to a positive short-term impact on the stock price. The specific mention of a $124 price target suggests a significant upside potential from current levels, which could attract more buyers to the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100